fashion -WSS

fashion

author：comprehensive 2025-09-28 14:18:07 - browse：5

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said Tuesday.

Biogen’s chief executive, Christopher A. Viehbacher, said as the firm released fourth-quarter earnings that he had expected the slow uptake and sees considerable demand for the medication. He told reporters that 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month.

Before patients can get the drug, which costs $26,500-a-year, they must undergo a brain scan or a spinal tap to confirm that they have build-up of deposits of a sticky toxic protein called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

hotspot

WSS

Health AI: on the border between health care and tech

How to protect coverage of PrEP

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

BMS, looking to build heart drug business, turns to AI for diagnosis

Montana youths win climate lawsuit against state for promoting fossil fuels

Hospitals are dialing back on venture capital investing

entertainment

fashion

entertainment

Drug repurposing or repositioning? The language matters

Severe heat forecast: Where scorching temperatures will persist over the next week

Heart attack and stroke risk calculators need revising

Dozens dead from Maui wildfires: What we know about the victims

Dobbs anniversary: the lost opportunity of abortion as health care

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Wildfire smoke exposes gaps in outdoor worker protections

Sophia Smith scores twice for US in in 3

Medical records are filled with copy

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

focus

Indictment alleges Trump's ex

Patients, digital health players weigh in on FTC's data privacy plan

My chronic pain journey would have been easier knowing 5 things % STAT

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Novartis develops a rapidly manufactured CAR

The response to Covid

focus

focus

hotspot

leisure time